Examples of beta-blockers in the following topics:
-
Agonists, Antagonists, and Drugs
- Beta blockers (sometimes written as β-blockers) or beta-adrenergic blocking agents, beta-adrenergic antagonists, beta-adrenoreceptor antagonists, or beta antagonists, are a class of drugs used for various indications.
- As beta-adrenergic receptor antagonists, they diminish the effects of epinephrine (adrenaline) and other stress hormones.
- Beta blockers block the action of endogenous catecholamines—epinephrine (adrenaline) and norepinephrine (noradrenaline) in particular—on β-adrenergic receptors, part of the sympathetic nervous system that mediates the fight-or-flight response.
-
Signs and Symptoms of Shock
- While a fast heart rate is common, those on beta blockers and those who are athletic may have a normal or slow heart rate.
-
Raynaud's Phenomenon
- Drugs which may cause secondary Raynaud's include beta-blockers, chemotherapeutics, and anthrax vaccines.
- Raynaud's can also be treated with medications that prevent vasoconstriction, such as calcium channel blockers.
-
Asthma
- Treatment of acute symptoms is usually with an inhaled short-acting beta-2 agonist (such as salbutamol).
- The most common triggers include allergens, smoke (tobacco and other), air pollution, non selective beta-blockers, and sulfite-containing foods.
-
Marfan Syndrome
- Beta blockers have been used to control arrhythmias and slow the heart rate.
-
Thyroid Gland Disorders
- In the case of Graves' disease, beta blockers are used to decrease symptoms of hyperthyroidism and anti-thyroid drugs are used to decrease the production of thyroid hormones.
-
Prostate Disorders
- Chronic non-bacterial prostatitis or male chronic pelvic pain syndrome (category III), which comprises about 95% of prostatitis diagnoses, is treated by a large variety of modalities including alpha blockers, phytotherapy, physical therapy, psychotherapy, antihistamines, anxiolytics, nerve modulators, surgery, and other treatments.
-
Type 1 Diabetes Mellitus
- Diabetes mellitus type 1 results from autoimmune destruction of insulin-producing beta cells of the pancreas and is potentially fatal.
- Diabetes mellitus type 1 (Type 1 diabetes, T1DM, formerly insulin-dependent or juvenile diabetes) is a form of diabetes mellitus that results from autoimmune destruction of insulin-producing beta cells of the pancreas.
- The pathophysiology in diabetes type 1 is basically a destruction of beta cells in the pancreas, regardless of which risk factors or causative entities have been present.
- Some researchers believe it might be prevented at the latent autoimmune stage, before it starts destroying beta cells.
- Experimental replacement of beta cells (by transplant or from stem cells) is being investigated in several research programs.
-
Types of Cells in the Pancreas
- Beta cells that produce insulin and amylin, and make up 65–80% of the total islet cells.
- The hormone glucagon activates alpha cells which then activate beta cells and delta cells.
- The right image is the same section stained by immunofluorescence against insulin, indicating beta cells.
-
Overview of Pancreatic Islets
- Beta cells that produce insulin and amylin and make up 65–80% of the total islet cells.
- Insulin activates beta cells and inhibits alpha cells, while glucagon activates alpha cells, which activates beta cells and delta cells.
- Somatostatin inhibits the activity of alpha cells and beta cells.
- The small cells in the middle are beta cells, and the surrounding larger cells are alpha, delta, gamma, and epsilon cells.